How peptides degrade, and what slows itWhat the studies show

Four reactions wear peptides down — deamidation, oxidation, hydrolysis and aggregation — and every one of them needs water, heat, light or the wrong pH.

5 min read · Mixed evidence · Updated November 2026

In short

Name
peptide stability
Evidence
Mixed evidence
Bottom line
Settled chemistry from decades of pharmaceutical stability work; the pathways are well mapped and the rates are specific to each sequence.

Before you read this

This guide explains what published studies found. That is all it is.

It is not medical advice and it is not instructions for using anything. Where a dose appears, we are reporting what a named study gave the people or animals in it — a fact about the study, not an instruction to you.

The compounds here are not approved by the FDA for use in people and are sold for laboratory research only. A study tells you what happened to the subjects in it; it does not tell you what would happen to you. Talk to a doctor first.

What it is

A peptide is a chain of amino acids held together by amide bonds, and some of those amino acids carry side chains that are chemically reactive. Left in water at room temperature, a peptide is slowly rewritten: amide groups fall off, sulfur atoms oxidise, the backbone breaks, and the chains stick to one another. The field that studies this is protein pharmaceutical stability, and its standard review, last updated in 2010, divides the damage into chemical pathways, which change the covalent structure, and physical ones, which change how chains fold and associate 1. Each has its own triggers, and a peptide's sequence decides which of them matter most.

The rest of this guide is free

Unlock the How peptides degrade, and what slows it guide — and every other one

What the studies found, what they didn't, every source linked. Enter your email once; the link we send opens all of them on this device, plus one plain-language study breakdown a week.

Terms

These guides explain what published studies found. That is all they are. They are not medical advice, and they are not instructions for using anything. Nothing here is meant to diagnose, treat, cure or prevent any illness. The compounds discussed on this site are not approved by the FDA for use in people. Research compounds are sold for laboratory use only, not for use in humans or animals. A study tells you what happened to the people or animals in it. It does not tell you what would happen to you. What you do with what you read here is your responsibility, so talk to a doctor first. This site is published by Progression Labs, which sells research compounds.

Deamidation

Asparagine and, more slowly, glutamine carry an amide on their side chain that can attack the backbone next to it, forming a five-membered ring that then opens into either aspartate or its isomer, isoaspartate. The peptide gains a negative charge and often a kink, and on a chromatogram it appears as a new peak just ahead of the parent. The speed depends on the next residue: with glycine following asparagine, the half-life at 37 °C and neutral pH can be a day or two; with a bulky residue following, it can be over a year 2. Robinson and Robinson measured these rates across a large set of model peptides and proposed that deamidation acts as a molecular clock, which is a way of saying that it runs whether anyone wants it to or not 2. It is fastest at neutral to alkaline pH, slower in mildly acidic solution, and it needs water: in the dry solid it all but stops.

Oxidation

Three side chains are vulnerable to oxygen and its reactive forms: methionine, which becomes methionine sulfoxide; cysteine, which pairs into disulfides or oxidises further; and tryptophan, with histidine and tyrosine behind it 3. The oxidants are ordinary — dissolved oxygen, traces of peroxide in excipients, metal ions that catalyse radical formation — and light drives a separate route, photo-oxidation, in which tryptophan absorbs ultraviolet and passes the energy to oxygen 3. A 1995 review from Borchardt's group catalogues these mechanisms and the standard defences used in formulation: keeping oxygen and metals out, keeping light off, and keeping the peptide out of solution 3.

Hydrolysis and aggregation

The amide bonds of the backbone themselves hydrolyse, slowly, and some much faster than others: the bond between aspartate and proline is the weak point, breaking in acid at rates that leave other bonds untouched, and the bonds on either side of aspartate come next 1. Hydrolysis is driven by acid and heat and, like deamidation, cannot happen without water.

Aggregation is physical rather than chemical. Chains that have partly unfolded expose hydrophobic patches and stick to one another, forming dimers, then soluble oligomers, then visible particles. A 2003 review from Carpenter and Randolph's group describes the process as a competition between the native fold and partly unfolded states, pushed toward the latter by heat, by surfaces such as the air–water interface, by agitation and by freeze–thaw cycles 4. Aggregates can be reversible or not, and they are the form of damage most likely to change what a peptide does biologically rather than just how much of it is left.

Why peptides are shipped dry

Every reaction above runs faster as temperature rises, roughly doubling or tripling for each 10 °C, which is ordinary chemistry 1. But the single variable that touches all of them is water. In a lyophilised solid the molecules are locked in a glass, cannot diffuse to find each other or an oxidant, and have no solvent in which to hydrolyse or deamidate; Lai and Topp's 1999 review of solid-state stability shows degradation rates falling by orders of magnitude from solution to dry powder, and rising again as residual moisture creeps up and the glass softens 5. That is why a peptide that would last days in solution at room temperature lasts months or years as a cake, why residual moisture is a release specification, and why the words cold, dark and dry on a shipping label are three different chemical statements rather than one piece of caution.

What these studies are, and aren't

Mixed evidence. Settled chemistry from decades of pharmaceutical stability work; the pathways are well mapped and the rates are specific to each sequence.

Sources

  1. 1Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010 (review).
  2. 2Robinson NE, Robinson AB. Molecular clocks. Proceedings of the National Academy of Sciences, 2001.
  3. 3Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnology and Bioengineering, 1995 (review).
  4. 4Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharmaceutical Research, 2003 (review).
  5. 5Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. Journal of Pharmaceutical Sciences, 1999 (review).

More in How peptides work